Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 1054

Results For "CE"

11054 News Found

Thermo Fisher opens biologics site in Lengnau, Switzerland
News | October 04, 2021

Thermo Fisher opens biologics site in Lengnau, Switzerland

The state-of-the-art facility provides a pathway from development to large-scale biologics production


Biocon launches Everolimus tablets in the US
Drug Approval | October 04, 2021

Biocon launches Everolimus tablets in the US

According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021


Lilly to transfer rights of two diabetes drugs to Cipla in India
Drug Approval | October 04, 2021

Lilly to transfer rights of two diabetes drugs to Cipla in India

Lilly will continue to maintain its existing operating model for the remaining portfolio of products


Samir Mehta of Torrent is the new President of IPA for 2021-23
Appointment | October 04, 2021

Samir Mehta of Torrent is the new President of IPA for 2021-23

Torrent is one of India's fastest-growing pharma majors


Samina Hamied of Cipla is the new VP of the IPA for 2021-23
Appointment | October 04, 2021

Samina Hamied of Cipla is the new VP of the IPA for 2021-23

Cipla is a leading global pharma company


Max Healthcare to construct two 500-bed hospitals in Gurugram
Hospitals | October 04, 2021

Max Healthcare to construct two 500-bed hospitals in Gurugram

The two plots are located in the heart of Gurugram close to Sectors 53 on the Golf Course Road and Sector 56 just minutes away from the other location


Veeda Clinical Research files DRHP for Rs 831 crore IPO
News | October 01, 2021

Veeda Clinical Research files DRHP for Rs 831 crore IPO

The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders


Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
Biotech | October 01, 2021

Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy

Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval


Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients
Biotech | October 01, 2021

Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients

If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic


Global Health files DRHP for over Rs 500 crore issue
News | October 01, 2021

Global Health files DRHP for over Rs 500 crore issue

Global Health operates a network of four hospitals under the Medanta brand in Gurugram, Indore, Ranchi and Lucknow. In addition, one hospital is under construction in Patna, and another is planned for development in Noida